These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 17335813

  • 1. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
    Nahrevanian H, Farahmand M, Aghighi Z, Assmar M, Amirkhani A.
    Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with Leishmania major.
    Nahrevanian H, Hajihosseini R, Arjmand M, Farahmand M, Ghasemi F.
    Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1188-98. PubMed ID: 20578452
    [Abstract] [Full Text] [Related]

  • 3. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M, Rivera-Montoya I, Espinoza A, Romero-Grijalva M, López-Flores R, González J, Terrazas LI.
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [Abstract] [Full Text] [Related]

  • 4. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK, Lonardoni MV, Grespan R, Caparroz-Assef SM, Cuman RK, Bersani-Amado CA.
    J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
    [Abstract] [Full Text] [Related]

  • 5. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E, Belkaid Y, Nguyen B, Wilson M, Sacks DL, Udey MC.
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [Abstract] [Full Text] [Related]

  • 6. Anti-leishmanial effects of trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway.
    Nahrevanian H, Najafzadeh M, Hajihosseini R, Nazem H, Farahmand M, Zamani Z.
    Korean J Parasitol; 2009 Jun; 47(2):109-15. PubMed ID: 19488416
    [Abstract] [Full Text] [Related]

  • 7. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS, de Souza GF, de Oliveira MG, Abrahamsohn Ide A.
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [Abstract] [Full Text] [Related]

  • 8. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis.
    Fonseca SG, Romão PR, Figueiredo F, Morais RH, Lima HC, Ferreira SH, Cunha FQ.
    Eur J Immunol; 2003 Aug; 33(8):2297-306. PubMed ID: 12884305
    [Abstract] [Full Text] [Related]

  • 9. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG, Duarte MC, Oliveira JS, Chávez-Fumagalli MA, Martins VT, Costa LE, Leite JP, Santoro MM, Régis WC, Tavares CA, Coelho EA.
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [Abstract] [Full Text] [Related]

  • 10. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
    Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P.
    J Immunol; 1996 Jul 15; 157(2):827-35. PubMed ID: 8752935
    [Abstract] [Full Text] [Related]

  • 11. Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages.
    Stefani MM, Müller I, Louis JA.
    Eur J Immunol; 1994 Mar 15; 24(3):746-52. PubMed ID: 7510243
    [Abstract] [Full Text] [Related]

  • 12. In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production.
    Gamboa-León MR, Aranda-González I, Mut-Martín M, García-Miss MR, Dumonteil E.
    Scand J Immunol; 2007 Nov 15; 66(5):508-14. PubMed ID: 17953527
    [Abstract] [Full Text] [Related]

  • 13. Leishmania major: in vitro and in vivo anti-leishmanial effect of cantharidin.
    Ghaffarifar F.
    Exp Parasitol; 2010 Oct 15; 126(2):126-9. PubMed ID: 20435039
    [Abstract] [Full Text] [Related]

  • 14. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC, Zauli-Nascimento RC, Yokoyama-Yasunaka JK, Katz S, Barbiéri CL, Uliana SR.
    J Antimicrob Chemother; 2009 Feb 15; 63(2):365-8. PubMed ID: 19095684
    [Abstract] [Full Text] [Related]

  • 15. Reactive nitrogen intermediate production and tolerance variability in different mouse strains after in vivo treatment with lipopolysaccharide from Salmonella abortus equi.
    Nahrevanian H, Salmasi JG, Farahmand M, Aghighi Z, Assmar M, Abolhassani M.
    J Microbiol Immunol Infect; 2005 Jun 15; 38(3):164-8. PubMed ID: 15986065
    [Abstract] [Full Text] [Related]

  • 16. [Leishmaniasis: principles of the immune response and function of nitric oxide].
    Bogdan C.
    Berl Munch Tierarztl Wochenschr; 1998 Jun 15; 111(11-12):409-14. PubMed ID: 9880934
    [Abstract] [Full Text] [Related]

  • 17. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase.
    Blos M, Schleicher U, Soares Rocha FJ, Meissner U, Röllinghoff M, Bogdan C.
    Eur J Immunol; 2003 May 15; 33(5):1224-34. PubMed ID: 12731047
    [Abstract] [Full Text] [Related]

  • 18. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium.
    Xu D, McSorley SJ, Tetley L, Chatfield S, Dougan G, Chan WL, Satoskar A, David JR, Liew FY.
    J Immunol; 1998 Feb 01; 160(3):1285-9. PubMed ID: 9570545
    [Abstract] [Full Text] [Related]

  • 19. Mast cell degranulation contributes to susceptibility to Leishmania major.
    Romão PR, Da Costa Santiago H, Ramos CD, De Oliveira CF, Monteiro MC, De Queiroz Cunha F, Vieira LQ.
    Parasite Immunol; 2009 Mar 01; 31(3):140-6. PubMed ID: 19222785
    [Abstract] [Full Text] [Related]

  • 20. Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB/c mice.
    Soudi S, Hosseini AZ, Hashemi SM.
    Parasite Immunol; 2011 Oct 01; 33(10):561-71. PubMed ID: 21781137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.